Iron supplementation to treat anemia in patients with chronic kidney disease
- 19 October 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Nephrology
- Vol. 6 (12), 699-710
- https://doi.org/10.1038/nrneph.2010.139
Abstract
Iron deficiency is prevalent in patients with chronic kidney disease (CKD), and use of oral and intravenous iron in patients with CKD who do not require dialysis might obviate or delay the need for treatment with eythropoiesis-stimulating agents (ESAs). Patients on hemodialysis have lower intestinal iron absorption, greater iron losses, and require greater iron turnover to maintain the ESA-driven red cell mass than do healthy individuals. In these patients, intravenous iron reduces ESA dose requirements and increases the likelihood of maintaining levels of hemoglobin within the desired range. Oral iron is inferior to intravenous iron in patients on hemodialysis, in part because elevated serum levels of hepcidin prevent intestinal absorption of iron. Increased levels of hepcidin also impair the normal recycling of iron through the reticuloendothelial system. Levels of serum ferritin and transferrin saturation below 450 pmol/l and 20%, respectively are indicative of iron deficiency, but values above the normal range lack diagnostic value in patients with CKD on dialysis. The availability of various iron preparations and new developments in delivering iron should enable adequate provision of iron to patients with CKD. This Review examines the efficacy, safety and use of iron supplementation therapy for the treatment of anemia in patients with CKD.Keywords
This publication has 84 references indexed in Scilit:
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKDAmerican Journal of Kidney Diseases, 2010
- The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical studyNephrology Dialysis Transplantation, 2010
- Growth differentiation factor 15 in erythroid health and diseaseCurrent Opinion in Hematology, 2010
- Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of AnemiasAdvances in Hematology, 2009
- The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected dataBMC Nephrology, 2009
- Association of Serum Total Iron-Binding Capacity and Its Changes Over Time with Nutritional and Clinical Outcomes in Hemodialysis PatientsAmerican Journal of Nephrology, 2009
- Prevalence of Helicobacter pylori infection in long-term hemodialysis patientsKidney International, 2009
- Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in HemodialysisAmerican Journal of Kidney Diseases, 2008
- Erythroblastic islands: niches for erythropoiesisBlood, 2008
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002